Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Scientific Reports
|
December 19, 2022
Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD
Asako Nogami, Masato Yoneda, Michihiro Iwaki, et al.
Journal of Gastroenterology
|
October 3, 2021
Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan
Masato Yoneda, Takuma Yamamoto, Yasushi Honda, et al.
Journal of Pharmacological Sciences
|
August 13, 2021
Protective effect of SGL5213, a potent intestinal sodium-glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice
Yasushi Honda, Anna Ozaki, Michihiro Iwaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 15, 2022
Meta-analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease
Yasushi Honda, Masato Yoneda, Takashi Kobayashi, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
January 24, 2022
Gastroesophageal varices evaluation using spleen-dedicated stiffness measurement by vibration-controlled transient elastography
Koki Nagai, Yuji Ogawa, Takashi Kobayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 12, 2019
Assessment of 10-year changes in liver stiffness using vibration-controlled transient elastography in non-alcoholic fatty liver disease
Asako Nogami, Masato Yoneda, Takashi Kobayashi, et al.
BMJ Open Diabetes Research & Care
|
February 17, 2021
Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial
Masato Yoneda, Yasushi Honda, Yuji Ogawa, et al.
Scientific Reports
|
October 28, 2022
A 3-step approach to predict advanced fibrosis in nonalcoholic fatty liver disease: impact on diagnosis, patient burden, and medical costs
Takashi Kobayashi, Yuji Ogawa, Satoru Shinoda, et al.
Hepatology Communications
|
October 30, 2023
Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease
Michihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, et al.
BMJ Open
|
July 12, 2022
Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study
Michihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Scientific Reports
|
December 19, 2022
Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD
Asako Nogami, Masato Yoneda, Michihiro Iwaki, et al.
Journal of Gastroenterology
|
October 3, 2021
Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan
Masato Yoneda, Takuma Yamamoto, Yasushi Honda, et al.
Journal of Pharmacological Sciences
|
August 13, 2021
Protective effect of SGL5213, a potent intestinal sodium-glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice
Yasushi Honda, Anna Ozaki, Michihiro Iwaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 15, 2022
Meta-analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease
Yasushi Honda, Masato Yoneda, Takashi Kobayashi, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
January 24, 2022
Gastroesophageal varices evaluation using spleen-dedicated stiffness measurement by vibration-controlled transient elastography
Koki Nagai, Yuji Ogawa, Takashi Kobayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 12, 2019
Assessment of 10-year changes in liver stiffness using vibration-controlled transient elastography in non-alcoholic fatty liver disease
Asako Nogami, Masato Yoneda, Takashi Kobayashi, et al.
BMJ Open Diabetes Research & Care
|
February 17, 2021
Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial
Masato Yoneda, Yasushi Honda, Yuji Ogawa, et al.
Scientific Reports
|
October 28, 2022
A 3-step approach to predict advanced fibrosis in nonalcoholic fatty liver disease: impact on diagnosis, patient burden, and medical costs
Takashi Kobayashi, Yuji Ogawa, Satoru Shinoda, et al.
Hepatology Communications
|
October 30, 2023
Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease
Michihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, et al.
BMJ Open
|
July 12, 2022
Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study
Michihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, et al.
Page
of 5